Eosinophilic colitis (EoC) is a rare gastrointestinal (GI) disease that is not fully understood. It presents with different manifestations depending on the stratum and gastrointestinal area affected. EoC is characterized by intestinal inflammation rich in eosinophils, without any known causes of eosinophilia. Colon biopsies are required to identify this condition. It is not entirely clear whether EoC is a colonic manifestation of inflammatory bowel disease (IBD). To date, treatment has been based on steroids for an indefinite duration, dietary modification, and in some cases sodium cromoglycate and leukotriene receptor antagonists. We report the case of a 57 years old male patient who was admitted to the emergency department with persistent chronic diarrhea, abdominal pain, and malabsorption. After unsuccessful therapy with steroids and mesalazine, he received Lactobacillus Paracasei subsp. paracasei F19, which improved symptoms, endoscopic pattern, laboratoristic parameters and general condition.
To cite this article
Lactobacillus Paracasei subsp. paracasei f19 for the treatment of eosinophilic colitis: a case report and literature review
Microb Health Dis 2022;
Submission date: 09 Mar 2022
Revised on: 18 Mar 2022
Accepted on: 23 Mar 2022
Published online: 25 Mar 2022
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.